Sarepta Therapeutics's top three insider shareholders as of March 23, 2026 are Richard Barry (Director, 2.97Mn shares), Douglas S Ingram (Chief Executive Officer, 929.39K shares), Michael Andrew Chambers (Director, 284.03K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Louise Rodino-Klapac | President, Rd And Tech Ops | 225,323 | 0 | 13 Mar, 2026 |
| Ian Michael Estepan | Chief Operating Officer | 201,983 | 0 | 13 Mar, 2026 |
| Cristin Rothfuss | Evp, General Counsel | 137,544 | 0 | 13 Mar, 2026 |
| Ryan Ho-Yan Wong | Chief Financial Officer | 135,064 | 0 | 13 Mar, 2026 |
| Hans Lennart Rudolf Wigzell | 25,223 | 0 | 11 Mar, 2025 | |
| Stephen Mayo | 1,765 | 0 | 13 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Mar, 2026 | Louise Rodino-Klapac | Common Stock | D | 948 | $17.03 | 225,323 | D | F |
| 11 Mar, 2026 | Cristin Rothfuss | Common Stock | D | 974 | $17.03 | 137,544 | D | F |
| 12 Mar, 2026 | Stephen Mayo | Common Stock | D | 7,239 | $17.02 | 1,765 | D | S |
| 11 Mar, 2026 | Ian Michael Estepan | Common Stock | D | 1,097 | $17.03 | 201,983 | D | F |
| 11 Mar, 2026 | Ryan Ho-Yan Wong | Common Stock | D | 256 | $17.03 | 135,064 | D | F |
| 09 Mar, 2026 | Cristin Rothfuss | Common Stock | D | 484 | $16.95 | 138,864 | D | F |
| 09 Mar, 2026 | Ian Michael Estepan | Common Stock | D | 1,036 | $16.95 | 203,663 | D | F |
| 09 Mar, 2026 | Ryan Ho-Yan Wong | Common Stock | D | 162 | $16.95 | 135,433 | D | F |
| 09 Mar, 2026 | Louise Rodino-Klapac | Common Stock | D | 504 | $16.95 | 227,166 | D | F |
| 09 Mar, 2026 | Ryan Ho-Yan Wong | Common Stock | D | 113 | $16.95 | 135,320 | D | F |
| 09 Mar, 2026 | Louise Rodino-Klapac | Common Stock | D | 895 | $16.95 | 226,271 | D | F |
| 09 Mar, 2026 | Ian Michael Estepan | Common Stock | D | 583 | $16.95 | 203,080 | D | F |
| 09 Mar, 2026 | Cristin Rothfuss | Common Stock | D | 346 | $16.95 | 138,518 | D | F |
| 01 Mar, 2026 | Louise Rodino-Klapac | Common Stock | A | 8,125 | - | 232,155 | D | M |
| 02 Mar, 2026 | Ryan Ho-Yan Wong | Common Stock | D | 450 | $16.20 | 135,595 | D | F |
| 01 Mar, 2026 | Ian Michael Estepan | Common Stock | A | 8,125 | - | 208,875 | D | M |
| 02 Mar, 2026 | Cristin Rothfuss | Common Stock | D | 408 | $16.20 | 139,348 | D | F |
| 02 Mar, 2026 | Louise Rodino-Klapac | Common Stock | D | 3,718 | $16.20 | 228,437 | D | F |
| 02 Mar, 2026 | Ian Michael Estepan | Common Stock | D | 3,301 | $16.20 | 205,574 | D | F |
| 02 Mar, 2026 | Ian Michael Estepan | Common Stock | D | 875 | $16.20 | 204,699 | D | F |